首页> 外文OA文献 >Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)

【2h】

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)

机译：抗-间皮素疫苗CRS-207联合或不联合低剂量环磷酰胺加化学疗法作为恶性胸膜间皮瘤（MPM）的一线治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) [J] . Raffit Hassan, Evan Alley, Hedy Kindler, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：抗-间皮素疫苗CRS-207联合或不联合低剂量环磷酰胺加化学疗法作为恶性胸膜间皮瘤（MPM）的一线治疗
2. Mesothelin-targeted immunotherapy CRS-207 plus chemotherapy as treatment for malignant pleural mesothelioma (MPM) [J] . Hassan R., Alley E., Kindler H., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Suppla1期

机译：间皮素靶向免疫疗法CRS-207联合化学疗法治疗恶性胸膜间皮瘤（MPM）
3. Radiological Response Patterns in Malignant Pleural Mesothelioma (MPM): Subgroup Analyses of the Phase 2 Stellar Trial of TTFields Plus Chemotherapy for First-Line Treatment [J] . Grosso F., Ceresoli G. International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：恶性胸膜间皮瘤的放射反应模式（MPM）：TTFIELDS Plus化疗进行第一线治疗的第2期恒星试验的亚组分析
4. An MRM assay for HAPLN1 - a protein with potential as a prognostic marker for malignant pleural mesothelioma (MPM) [C] . Sofia Waldemarson, Chandra M.V. Goparaju, Asa Wahlander, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：HAPLN1的MRM测定 - 一种蛋白质，其具有恶性胸膜间皮瘤（MPM）的预后标志物
5. An economic analysis of the addition of bevacizumab to standard chemotherapy in patients with malignant pleural mesothelioma. [D] . Malacan, Jean. 2016

机译：恶性胸膜间皮瘤患者在标准化疗中加用贝伐单抗的经济分析。
6. Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) [O] . Raffit Hassan, Evan Alley, Hedy Kindler, 2015

机译：抗-间皮素疫苗CRS-207联合或不联合低剂量环磷酰胺加化学疗法作为恶性胸膜间皮瘤（MPM）的一线治疗
7. 208O_PR: CRS-207 with chemotherapy (chemo) in malignant pleural mesothelioma (MPM): Results from a phase 1b trial [O] . T. Jahan, R. Hassan, E. Alley, 2016

机译：208O_PR：CRS-207具有化疗（Chemo）恶性胸膜间皮瘤（MPM）：阶段1B试验结果
8. Improving Outcome in Malignant Pleural Mesothelioma (MPM) Using Pulsed-Protracted External Beam Radiation (PERT) and Intrapleural Delivery of Stem Cells. [R] . Marples, B. 2014

机译：利用脉冲持续外照射（pERT）和胸腔内输送干细胞改善恶性胸膜间皮瘤（mpm）的预后。

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)

著录项

引文网络

相似文献

相关主题

期刊订阅